Cho, B. C., Penkov, K., Bondarenko, I., Korozan, M., Kurochkin, A., Pikiel, J., Kulyaba, Y., Ahn, H. K., Odintsova, S., Davda, J., Forgie, A., Wang, X., Li, R., Jacobs, I. A., Kazazi, F., Chou, J., & Johnson, M. L. (n.d.). 1275PSafety and clinical activity of subcutaneously (SC) administered anti-PD-1 antibody PF-06801591 in phase I dose-expansion cohorts of locally advanced or metastatic non-small cell lung cancer (NSCLC) and urothelial carcinoma (UC). Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100097084058.0x000022